A number of hormones.

A number of hormones, including hypothalamic neuropeptides acting as neurotransmitters and neuromodulators in the CN are involved in the physiologic regulation of breathing and participate in adjustment of breathing in disease. In addition to central issues some hormones also control breathing at peripheral chemoreceptors or have local validitys on the lungs and airways. Estrogen and progesterone be seen to protect from sleep-disordered breathing, whereas testosterone may predispose to it. Progesterone and thyroxine have protracted been known to stimulate respiration. More lately several hormones such as corticotropin-releasing hormone and leptin have been moveed to act as respiratory stimulants. Somatostatin, dopamine, and neuropeptide Y have a depressing drift on breathing. Animal models and experimental human studies propose that also many other hormones may be involved in respiratory control

solution words: control of breathing; dopamine; estrogen; hormones; insulin-like vegetation factor-1; leptin; progesterone; respiration; somatostatin; thyroxine

Abbreviations: AHI = apnea-hypopnea index; CPAP = continuous positive airway pressure; CRH = corticotropin-releasing hormone; EMG = electromyogram; FSH=follicle-stimulating hormone; GABA = [gamma]-aminobutyric acid; GH = increase hormone; GHRH = growth hormone-releasing hormone; HCVR = hypercapnic ventilatory response; HVR = hypoxic ventilatory response; IGF = insulin-like development factor; LH = luteinizing hormone; MPA = medroxyprogesterone acetate; OSAS = obstructive doze apnea syndrome; REM = rapid watch movement; Sa[O.sub.2] = arterial oxyhemoglobin saturation; SW = slow-wave sleep; TRH = thyrotropin-releasing hormone; VIP = vasoactive intestinal peptide

**********

A textbook of endocrinology from 1985 stated that "respiration does not have a significant simple body of endocrine control." (1) With growing corpse of evidence on the interaction of respiration and hormones during the past 15 years, this statement has subsequently been omitted. (2) Today, the hinder of respiration encompasses both voluntary (cortex) and involuntary (emotional, metabolic, neural, and endocrine components) sway mechanisms.

The endocrine and nervous orders have complex interactions. The nervous body produces and liberates biochemical agents, which may act as locally or systemically via circulation. Several hormones wait on as neurogenic mediators within the CN Circulating hormones can have local or autocrine weights in the cells in which they are produc Locally synthesized hormones can diffuse into adjacent or nearby small cavitys to exert paracrine effects. The efficiency of a single hormone can differ in various tissues or in the same tissue at different eras of life span. The appearance of other hormonal or nonhormonal regulators may reinforce or hinder the action of a hormone. principally complex processes under endocrine sway such as respiration, are influenced by means of several hormones.

Respiration as a vital function is not regulated through specific hormones but is influenced by means of a wide array of hormones. The general bulk of evidence suggests that hormones have an important character in the regulation of breathing via several mechanisms. They may stimulate breathing (Table 1) at the flush of the CNS or at peripheral chemoreceptors (eg progesterone; Fig 1) or according to altering the basic metabolic rate, affecting indirectly also breathing (eg thyroid hormones). The long-term indirect efficiencys of hormones on breathing include adjustment for the acid-base balance, dead body temperature, and mass of muscle and fat. Endocrine agents may also have an result on the upper or lower airway patency. They may remodel upper airway collapsibility during lie in the grave (eg, progesterone) or may have bronchodilatory (eg epinephrine) or bronchoconstrictive (eg histamine) powers (Table 2). Obstructive sleep apnea syndrome (OSAS) affects serum hormone on a levels which may be recuperated with nasal continuous positive airway compressing (CPAP) treatment (Table 3). The prevalence of sleep-disordered breathing is increased in several endocrine disorders and after menopause (Tables 4 5) (3-23) However, these prevalence estimates should be interpreted cautiously because well-done epidemiologic studies are lacking in mostly endocrine disorders, and definition of slumber apnea varies between studies, resulting in wide variations in prevalence rates.

[FIGURE 1 OMITTED]

any respiratory effects of hormones have been known for decades. Hyperventilation and decreased PaC[O.sub.2] was first described during pregnancy (2425); later forward the same phenomenon was confirmed during the luteal phase of the menstrual period (26) The cyclic changes in respiration cease after menopause. (26) The weight of progesterone on breathing was confirmed 5 decades ago. (2728) Ventilatory replys differ between genders and vary according to the menstrual revolution of time phase. Women tend to have lower ventilatory answers than men. (29) The hypercapnic ventilatory answer (HCVR) is higher during the luteal phase than the follicular phase of the menstrual period (29) Except for the efficiencys of progesterone on breathing, the validity of the deficiency of the thyroid hormones onward breathing has also been known for decades. (30)

...